IL165195A0 - A buffered, liquid nicotine composition for pulmonary administration - Google Patents

A buffered, liquid nicotine composition for pulmonary administration

Info

Publication number
IL165195A0
IL165195A0 IL16519504A IL16519504A IL165195A0 IL 165195 A0 IL165195 A0 IL 165195A0 IL 16519504 A IL16519504 A IL 16519504A IL 16519504 A IL16519504 A IL 16519504A IL 165195 A0 IL165195 A0 IL 165195A0
Authority
IL
Israel
Prior art keywords
buffered
pulmonary administration
liquid nicotine
nicotine composition
composition
Prior art date
Application number
IL16519504A
Other languages
English (en)
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Publication of IL165195A0 publication Critical patent/IL165195A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL16519504A 2002-06-03 2004-11-14 A buffered, liquid nicotine composition for pulmonary administration IL165195A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201669A SE0201669D0 (sv) 2002-06-03 2002-06-03 New formulation and use thereof
PCT/SE2003/000890 WO2003101454A1 (fr) 2002-06-03 2003-05-30 Composition nicotinique liquide tamponnee pour administration dans les poumons

Publications (1)

Publication Number Publication Date
IL165195A0 true IL165195A0 (en) 2005-12-18

Family

ID=20288046

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16519504A IL165195A0 (en) 2002-06-03 2004-11-14 A buffered, liquid nicotine composition for pulmonary administration

Country Status (19)

Country Link
EP (1) EP1509227B9 (fr)
JP (2) JP4745658B2 (fr)
CN (1) CN100500148C (fr)
AR (1) AR039947A1 (fr)
AT (1) ATE444753T1 (fr)
AU (1) AU2003243074B2 (fr)
BR (1) BR0311451A (fr)
CA (1) CA2487699C (fr)
DE (1) DE60329592D1 (fr)
DK (1) DK1509227T3 (fr)
ES (1) ES2332405T3 (fr)
IL (1) IL165195A0 (fr)
MX (1) MXPA04012041A (fr)
NZ (1) NZ536863A (fr)
RU (1) RU2283111C2 (fr)
SE (1) SE0201669D0 (fr)
TW (1) TW200407142A (fr)
WO (1) WO2003101454A1 (fr)
ZA (1) ZA200409793B (fr)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
ES2285233T3 (es) 2002-12-20 2007-11-16 Niconovum Ab Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable.
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
BR122018075478B8 (pt) 2004-06-24 2023-10-31 Vertex Pharma moduladores de transportadores de cassete de ligação de atp
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
HUE049976T2 (hu) 2005-12-28 2020-11-30 Vertex Pharma N-[2,4-bisz(1,1-dimetil-etil)-5-hidroxi-fenil]-1,4-dihidro-4-oxo-kinolin-3-karboxamid amorf alakjának gyógyászati kompozíciói
WO2007104573A2 (fr) 2006-03-16 2007-09-20 Niconovum Ab Composition améliorée de tabac à priser
CN201067079Y (zh) 2006-05-16 2008-06-04 韩力 仿真气溶胶吸入器
NZ600865A (en) * 2007-09-14 2014-01-31 Vertex Pharma Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN201379072Y (zh) 2009-02-11 2010-01-13 韩力 一种改进的雾化电子烟
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
CN102612361B (zh) * 2009-09-16 2014-11-05 菲利普莫里斯生产公司 传送药物的改良装置和方法
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
CA2824970C (fr) 2011-02-11 2016-05-03 Batmark Limited Element inhalateur
US8903228B2 (en) 2011-03-09 2014-12-02 Chong Corporation Vapor delivery devices and methods
US9399110B2 (en) 2011-03-09 2016-07-26 Chong Corporation Medicant delivery system
MX356624B (es) 2011-03-09 2018-06-06 Chong Corp Sistema de entrega de medicamento.
RU2595971C2 (ru) 2011-09-06 2016-08-27 Бритиш Америкэн Тобэкко (Инвестментс) Лимитед Нагревание курительного материала
EP3892125A3 (fr) 2011-09-06 2022-01-05 Nicoventures Trading Limited Chauffage de substance fumable
AT511344B1 (de) 2011-10-21 2012-11-15 Helmut Dr Buchberger Inhalatorkomponente
US9907748B2 (en) * 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CN109966264A (zh) 2012-02-27 2019-07-05 沃泰克斯药物股份有限公司 药物组合物及其施用
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2504076A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB201215282D0 (en) 2012-08-28 2012-10-10 Kind Consumer Ltd An inhaler
GB201215273D0 (en) * 2012-08-28 2012-10-10 Kind Consumer Ltd Nicotine composition
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
GB2513639A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513637A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
CA3208137A1 (fr) * 2013-05-06 2014-11-13 Juul Labs, Inc. Formulations de sel de nicotine pour des dispositifs de generation d'aerosol et methodes connexes
US11202470B2 (en) 2013-05-22 2021-12-21 Njoy, Inc. Compositions, devices, and methods for nicotine aerosol delivery
GB2514893B (en) 2013-06-04 2017-12-06 Nicoventures Holdings Ltd Container
US10251422B2 (en) 2013-07-22 2019-04-09 Altria Client Services Llc Electronic smoking article
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
CN110664012A (zh) 2013-12-23 2020-01-10 尤尔实验室有限公司 蒸发装置系统和方法
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP3148982A1 (fr) * 2014-05-27 2017-04-05 R. J. Reynolds Tobacco Company Sels, co-cristaux, et complexes de co-cristaux de sels de nicotine
GB2528673B (en) 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) * 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
KR102574658B1 (ko) 2014-12-05 2023-09-05 쥴 랩스, 인크. 교정된 투여량 제어
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201505597D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Article for use with apparatus for heating smokable material
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
CN114656446A (zh) * 2015-11-25 2022-06-24 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
US9867397B2 (en) 2016-01-11 2018-01-16 Patrick Beymer Nicotine delivery system
UA125687C2 (uk) 2016-02-11 2022-05-18 Джуул Лебз, Інк. Заповнювальний картридж випарного пристрою та способи його заповнення
SG10202108578XA (en) 2016-02-11 2021-09-29 Juul Labs Inc Securely attaching cartridges for vaporizer devices
EP3423058A4 (fr) * 2016-02-29 2019-10-30 Nicogen Ltd. Formulation de nicotine et aérosols
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
KR20210009450A (ko) 2016-04-27 2021-01-26 니코벤처스 트레이딩 리미티드 전자 에어로졸 제공 시스템 및 전자 에어로졸 제공 시스템을 위한 증기화기
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
KR20200037220A (ko) * 2017-06-26 2020-04-08 누드 니코틴 인코포레이티드 니코틴 염 및 이의 제조 및 사용 방법
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration
GB201817864D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
CN113924004B (zh) 2019-06-07 2023-11-03 菲利普莫里斯生产公司 烟碱袋组合物
US11666713B2 (en) 2019-12-15 2023-06-06 Shaheen Innovations Holding Limited Mist inhaler devices
KR20220141284A (ko) 2019-12-15 2022-10-19 샤힌 이노베이션즈 홀딩 리미티드 초음파 미스트 흡입장치
US11730191B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US11730193B2 (en) 2019-12-15 2023-08-22 Shaheen Innovations Holding Limited Hookah device
US20240148053A9 (en) 2019-12-15 2024-05-09 Shaheen Innovations Holding Limited Hookah device
KR102704091B1 (ko) 2019-12-15 2024-09-09 샤힌 이노베이션즈 홀딩 리미티드 미스트 흡입장치
EP3856304B1 (fr) 2019-12-15 2023-11-08 Shaheen Innovations Holding Limited Nébulisateur à ultrasons
US11589610B2 (en) 2019-12-15 2023-02-28 Shaheen Innovations Holding Limited Nicotine delivery device having a mist generator device and a driver device
EP3855949A4 (fr) 2019-12-15 2021-08-04 Shaheen Innovations Holding Limited Inhalateur de brume ultrasonore
US20230188901A1 (en) 2021-12-15 2023-06-15 Shaheen Innovations Holding Limited Apparatus for transmitting ultrasonic waves

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray

Also Published As

Publication number Publication date
AU2003243074A1 (en) 2003-12-19
MXPA04012041A (es) 2005-08-16
RU2004139067A (ru) 2005-08-10
JP2010280721A (ja) 2010-12-16
EP1509227B1 (fr) 2009-10-07
RU2283111C2 (ru) 2006-09-10
NZ536863A (en) 2007-05-31
DK1509227T3 (da) 2010-02-01
ZA200409793B (en) 2006-08-30
CN100500148C (zh) 2009-06-17
ATE444753T1 (de) 2009-10-15
BR0311451A (pt) 2005-03-15
EP1509227A1 (fr) 2005-03-02
JP2005533770A (ja) 2005-11-10
JP5430525B2 (ja) 2014-03-05
TW200407142A (en) 2004-05-16
DE60329592D1 (de) 2009-11-19
JP4745658B2 (ja) 2011-08-10
CA2487699C (fr) 2012-04-17
WO2003101454A1 (fr) 2003-12-11
AR039947A1 (es) 2005-03-09
ES2332405T3 (es) 2010-02-04
CA2487699A1 (fr) 2003-12-11
CN1658876A (zh) 2005-08-24
EP1509227B9 (fr) 2010-05-19
SE0201669D0 (sv) 2002-06-03
AU2003243074B2 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
IL165195A0 (en) A buffered, liquid nicotine composition for pulmonary administration
IL158862A0 (en) An insulin composition for pulmonary administration
IL177798A0 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
PL375551A1 (en) Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
GB2394894B (en) New use for pharmaceutical composition
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
HK1072597A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
HK1099753A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
HK1099748A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
PT1838683E (pt) Um processo para a preparação de derivados de [1,4,5]-oxadiazepina
EP1625844A4 (fr) Composition a usage externe administree par voie percutanee
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
AU3201701A (en) Pharmaceutical composition for pulmonary delivery
AU2003263113A8 (en) Dispensers particularly, but not exclusively, for cigarette packets
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
ZA200703562B (en) 1,5-diheterocycle-1H-triazole derivative
GB0308771D0 (en) Pulmonary drug delivery
EP1711189A4 (fr) Derives d'azalide 8a 6,11-3c-bicyclique
EP1515960A4 (fr) Derive de 2-thioxothiazole, procede de preparation de ce derive et composition pharmaceutique contenant ce derive
AU2003232684A8 (en) Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
EP1693067A4 (fr) Composition pharmaceutique anti-herpetique, procede de production d'une forme medicamenteuse a partir de cette composition et procede d'utilisation correspondant
ZA200402034B (en) A pharmaceutical composition.
PL113640U1 (en) Dispenser, particularly for cigarettes